CMS Action Aims to Lower Prescription Drug Prices, Increase Cost Transparency – Drug for nerve pain boosts high for opioid abusers.

2507_GraphicImage_062315-piAabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

CMS Action Aims to Lower Prescription Drug Prices, Increase Cost Transparency – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

The Centers for Medicare & Medicaid Services (CMS) issued a final rule Thursday for improving and modernizing the Medicare Advantage and Part D programs.1

However, the changes are not enough for some pharmacy direct and indirect remuneration fee (DIR) reform advocates.2

The CMS’ final rule aims to ensure that patients have greater transparency into the cost of prescription drugs in Part D with the ability to compare options and demand value from pharmaceutical companies.3

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.